These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27462869)

  • 1. Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease.
    Franceschini D; De Rose F; Fogliata A; Navarria P; Ascolese AM; Franzese C; Comito T; Tozzi A; Iftode C; Di Brina L; D'Agostino G; Clerici E; Cozzi L; Scorsetti M
    Oncotarget; 2016 Aug; 7(33):53321-53329. PubMed ID: 27462869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients.
    Alongi F; Fogliata A; Clerici E; Navarria P; Tozzi A; Comito T; Ascolese AM; Clivio A; Lobefalo F; Reggiori G; Cozzi L; Mancosu P; Tomatis S; Scorsetti M
    Radiat Oncol; 2012 Dec; 7():204. PubMed ID: 23216821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.
    Franzese C; Fogliata A; Comito T; Tozzi A; Iftode C; Clerici E; Franceschini D; Navarria P; Ascolese AM; Di Brina L; De Rose F; D'Agostino GR; Cozzi L; Scorsetti M
    Br J Radiol; 2017 Nov; 90(1079):20170422. PubMed ID: 28869396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer : A retrospective study of elderly patients with stage III disease.
    Franceschini D; De Rose F; Cozzi L; Navarria P; Clerici E; Franzese C; Comito T; Tozzi A; Iftode C; D'Agostino G; Sorsetti M
    Strahlenther Onkol; 2017 May; 193(5):385-391. PubMed ID: 28168322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
    Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases.
    Bignardi M; Navarria P; Mancosu P; Cozzi L; Fogliata A; Tozzi A; Castiglioni S; Carnaghi C; Tronconi MC; Santoro A; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):831-8. PubMed ID: 20800375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional control and survival after lymph node SBRT in oligometastatic disease.
    Loi M; Frelinghuysen M; Klass ND; Oomen-De Hoop E; Granton PV; Aerts J; Verhoef C; Nuyttens J
    Clin Exp Metastasis; 2018 Oct; 35(7):625-633. PubMed ID: 29995254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis.
    Nicosia L; Franzese C; Mazzola R; Franceschini D; Rigo M; D'agostino G; Corradini S; Alongi F; Scorsetti M
    Strahlenther Onkol; 2020 Mar; 196(3):213-221. PubMed ID: 31559480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Stereotactic Body Radiation Therapy with Volumetric-Modulated Arcs and High-Intensity Photon Beams for the Treatment of Abdomino-Pelvic Lymph-Node Metastases.
    Franzese C; Cozzi L; Franceschini D; D'Agostino G; Comito T; De Rose F; Navarria P; Mancosu P; Tomatis S; Fogliata A; Scorsetti M
    Cancer Invest; 2016 Aug; 34(7):348-54. PubMed ID: 27414125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.
    Croker J; Chua B; Bernard A; Allon M; Foote M
    Clin Exp Metastasis; 2016 Feb; 33(2):125-32. PubMed ID: 26482476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer.
    Jereczek-Fossa BA; Piperno G; Ronchi S; Catalano G; Fodor C; Cambria R; Fossati Ing P; Gherardi F; Alterio D; Zerini D; Garibaldi C; Baroni G; De Cobelli O; Orecchia R
    Am J Clin Oncol; 2014 Jun; 37(3):227-33. PubMed ID: 22992626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy?
    Franceschini D; Bianciardi F; Mazzola R; De Rose F; Gentile P; Alongi F; Scorsetti M
    Br J Radiol; 2019 Nov; 92(1103):20181026. PubMed ID: 31529985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.
    Franzese C; Fogliata A; D'Agostino GR; Di Brina L; Comito T; Navarria P; Cozzi L; Scorsetti M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1301-1309. PubMed ID: 28271215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
    Jouglar E; Thomas L; de la Rochefordière A; Noël G; Le Blanc-Onfroy M; Delpon G; Campion L; Mahé MA
    Cancer Radiother; 2016 Dec; 20(8):794-800. PubMed ID: 28270323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'?
    Jereczek-Fossa BA; Muto M; Durante S; Ferrari A; Piperno G; Fodor C; Comi S; Ricotti R; Garibaldi C; Dicuonzo S; Mazza S; Golino F; Spaggiari L; De Marinis F; Orecchia R; Ciardo D; Fossati P
    Acta Oncol; 2018 Nov; 57(11):1532-1539. PubMed ID: 30280618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
    Franzese C; Fogliata A; Clerici E; Franceschini D; Villa E; D'Agostino G; Navarria P; Mancosu P; Tomatis S; Cozzi L; Scorsetti M
    Radiat Oncol; 2015 Nov; 10():224. PubMed ID: 26545871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.